代谢相关性脂肪肝病的中西医治疗进展

Advances in the treatment of metabolic associated fatty liver disease by traditional chinese and western medicine

近几年,随着人民生活水平的提高,饮食脂肪含量的增加及不健康的生活方式导致的肥胖、高脂血症及糖尿病等由此引起的代谢相关性脂肪肝病(MAFLD)的发病率呈明显的上升趋势。MAFLD并非是一种良性和静止的病变,会逐渐引起炎症细胞浸润、坏死、纤维化及可能发展成为肝癌。现代医学对MAFLD的防治并无特效疗法,而中医中药防治MAFLD取得了一些进展。目前,人们对于MAFLD采用西医治疗还是中医治疗的问题上争论不止。本文就近几年西医、中医对MAFLD临床治疗进展做一综述。

Metabolic-associated fatty liver disease(MAFLD)as a new concept proposed by the 2020 international consensus has affected nearly a quarter of the global population.As people's living standards improve,the incidence of MAFLD,caused by the increase of dietary fat content and obesity,hyperlipidemia and diabetes which are caused by unhealthy lifestyle,are on the rise.MAFLD is not a benign and quiescent lesion that gradually develops into inflammatory cell infiltration,necrosis,fibrosis,and possibly liver cancer.As a result,MAFLD prevention and treatment research has also become the focus of medical research.There is no special treatment for the prevention and treatment of MAFLD in modern medicine,and some progress has been made in the prevention and treatment MAFLD traditional Chinese medicine.At present,there are more and more debates about the MAFLD of western medicine treatment or traditional Chinese medicine treatment.This paper reviewed the analysis of Clinical treatment of MAFLD by western medicine and traditional Chinese medicine in recent years.